| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |